Literature DB >> 23183840

Hypertension: Synergy of antihypertensives in elderly patients with CKD.

Ravi Nistala1, James R Sowers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183840      PMCID: PMC4349578          DOI: 10.1038/nrneph.2012.264

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Return of calcium: manipulating intracellular calcium to prevent cardiac pathologies.

Authors:  Yibin Wang; Joshua I Goldhaber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

2.  Central blood pressure under angiotensin and calcium channel blockade.

Authors:  Michel E Safar; Athanase Protogerou; Jacques Blacher
Journal:  Hypertension       Date:  2009-08-10       Impact factor: 10.190

3.  Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.

Authors:  Masanori Abe; Noriaki Maruyama; Kazuyoshi Okada; Shiro Matsumoto; Koichi Matsumoto; Masayoshi Soma
Journal:  Hypertens Res       Date:  2011-06-09       Impact factor: 3.872

4.  Exposure of luminal membranes of LLC-PK1 cells to ANG II induces dimerization of AT1/AT2 receptors to activate SERCA and to promote Ca2+ mobilization.

Authors:  Fernanda M Ferrão; Lucienne S Lara; Flavia Axelband; Juliana Dias; Adriana K Carmona; Rosana I Reis; Claudio M Costa-Neto; Adalberto Vieyra; Jennifer Lowe
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-04

5.  Renal outcomes in hypertensive Black patients at high cardiovascular risk.

Authors:  Matthew R Weir; George L Bakris; Michael A Weber; Bjorn Dahlof; Richard B Devereux; Sverre E Kjeldsen; Bertram Pitt; Jackson T Wright; Roxzana Y Kelly; Tsushung A Hua; R Allen Hester; Eric Velazquez; Kenneth A Jamerson
Journal:  Kidney Int       Date:  2011-12-21       Impact factor: 10.612

6.  Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.

Authors:  Pernille B Hansen; Christian B Poulsen; Steen Walter; Niels Marcussen; Leanne L Cribbs; Ole Skøtt; Boye L Jensen
Journal:  Hypertension       Date:  2011-07-25       Impact factor: 10.190

7.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.

Authors:  Wilbert S Aronow; Jerome L Fleg; Carl J Pepine; Nancy T Artinian; George Bakris; Alan S Brown; Keith C Ferdinand; Mary Ann Forciea; William H Frishman; Cheryl Jaigobin; John B Kostis; Giuseppi Mancia; Suzanne Oparil; Eduardo Ortiz; Efrain Reisin; Michael W Rich; Douglas D Schocken; Michael A Weber; Deborah J Wesley
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

8.  Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

Authors:  David S Wald; Malcolm Law; Joan K Morris; Jonathan P Bestwick; Nicholas J Wald
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

9.  An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.

Authors:  Shokei Kim-Mitsuyama; Hisao Ogawa; Kunihiko Matsui; Tomio Jinnouchi; Hideaki Jinnouchi; Kikuo Arakawa
Journal:  Kidney Int       Date:  2012-10-10       Impact factor: 10.612

Review 10.  Olmesartan/amlodipine: a review of its use in the management of hypertension.

Authors:  R Kreutz
Journal:  Vasc Health Risk Manag       Date:  2011-03-29
  10 in total
  2 in total

Review 1.  Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.

Authors:  Guanghong Jia; Yan Jia; James R Sowers
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-29       Impact factor: 5.187

Review 2.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.

Authors:  Guanghong Jia; Vincent G DeMarco; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.